System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Petros P Sfikakis is an expert in Rheumatology at Laiko General Hospital of Athens (Greece). As of October 2026, ScienceLeadR ranks Petros P Sfikakis in the top 1% of experts worldwide for Vasculitis and Scleroderma, Systemic, and in the top 1% of experts in Greece for Uveitis. Petros P Sfikakis has authored 937 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 2 of them ongoing. SLR score: 3,215 (community average: 125). How the SLR is computed.

LeadR Profile

Petros P Sfikakis Laiko General Hospital of Athens Greece
3 215 ScienceLeadR Reputation 3215

Unlock

Register Login
Network Map

Rheumatology

Subspecialties: Cardiology - Nutrition - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1990 - 2026
Source: PubMed

Laiko General Hospital of Athens

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 937

Citations

Citations: 25 496 1st author: 56 Last author: 247 Unique author: 5

Main journals

Ann Rheum Dis 114
Rheumatology (Oxford) 58
Clin Exp Rheumatol 29
Rheumatol Int 27
Clin Immunol 20

Best Journals

Eur Heart J 5
N Engl J Med 3
Eur Respir J 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Midlife physical activity trajectories are associated with reduced physical pre-frailty/frailty in older age: insights from the prospective ATTICA sub-study 2002-2024.
PMID 42895852 — diabetes mellitus, exercise, hypertension, confidence intervals, life style, cohort studies, frailty, hypercholesterolemia		J Frailty Aging20260
Retraction Note: Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma.
PMID 42881241 — dna repair, neoplasms, chromatin, drug therapy, multiple myeloma, chemotherapy		Br J Cancer20260
Proton pump inhibitor use and long-term outcomes in SSc: a real-life analysis from the EUSTAR database.
PMID 42760267 — mortality, phenotype, rheumatic diseases, proton pump inhibitors, proton pumps, lung diseases, interstitial		Rheumatology (Oxford)20260
Baricitinib retention and factors associated thereof in clinical practice: a prospective, multicenter 12-month study in rheumatoid arthritis patients.
PMID 42832028 — depression, hypertension, rheumatology, comorbidity, latent tuberculosis, arthritis, arthritis, rheumatoid, therapeutics, retention, psychology		Rheumatol Int20260
Effectiveness of oral anticoagulants in precapillary pulmonary hypertension associated with systemic sclerosis: a EUSTAR cohort study.
PMID 42758145 — sclerosis, hypertension, anticoagulants, hypertension, pulmonary, cohort studies, propensity score, rheumatic diseases, therapeutics, scleroderma, systemic		Rheumatology (Oxford)20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 7
Phase 3 6
Phase 2 2
Early Phase 1 1
Phase 3/Phase 4 1
Phase 4 1

By status:

Completed 11
Recruiting 3
Terminated 2
Unknown 2

By type:

Interventional 12
Observational 6

By Monocentric/Multicentric:

monocentric 5
multicentric2to4 2
multicentric5to9 0
multicentricup10 11

Main Topics

Cohort/Consortium Investigators 10

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Cortisol Circadian Rhythm in Patients With RA
NCT05671627 — cytokines, adrenal cortex, glucocorticoids, prednisone, hypothalamus, circadian rhythm, stress, physiological, adrenal cortex hormones, arthritis, arthritis, rheumatoid, therapeutics, hydrocortisone, steroids		N/ARecruiting2022
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease
NCT05168215 — skin, sclerosis, skin ulcer, blood, scleroderma, diffuse, pain, classification, ulcer, autoimmune diseases, bosentan, therapeutics, wounds and injuries, scleroderma, systemic		N/ARecruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS